
Misinformation About Fentanyl Exposure Threatens To Undermine Overdose Response
Fentanyl, the deadly synthetic opioid driving the nation’s high drug overdose rates, is also caught…
Fentanyl, the deadly synthetic opioid driving the nation’s high drug overdose rates, is also caught up in another increasingly serious problem: misinformation. False and misleading narratives on social media, in news reports, and even in popular television dramas suggesting people can overdose from touching fentanyl — rather than ingesting it — are now informing policy…
Aggressive deportation tactics have terrorized farmworkers at the center of the nation’s bird flu strategy, public health workers say. Dairy and poultry workers have accounted for most cases of the bird flu in the U.S. — and preventing and detecting cases among them is key to averting a pandemic. But public health specialists say they’re…
Because of past fraud by rogue brokers, some Affordable Care Act policyholders may get an unexpected tax bill this season. But that isn’t the only potential shock. Other changes coming soon — stemming from proposals by the administration of President Donald Trump — could affect their coverage and its cost. And sorting out related problems…
Through Teladoc’s new cardiometabolic health program, patients gain access to the BetterSleep app, a registered dietitian, health coaches, at-home testing and more. The post Teladoc Health Launches New Cardiometabolic Health Program appeared first on MedCity News.
Get notified about new policy research, polling, and news about the Medicaid financing debate and related issues.
OhioHealth is scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy during primary care visits. The post How One Health System Is Embedding Diabetic Retinopathy Screening Into Primary Care appeared first on MedCity News.
Solu Therapeutics’ platform technology, which was licensed from GSK, pairs a small molecule with an antibody to address elusive disease targets. Cancer is Solu’s initial focus, but the startup is also exploring applications of its platform to immunology. The post Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer appeared…
It was great fun to talk about the health care system with Dr Zeyad “Z” Baker on his podcast, so I thought I would share it here–Matthew Holt
Powered by People Rooted in Purpose The 2nd Annual Northeast Division Conference & Trade Show was a resounding success, bringing together more than 250 Environmental Services (EVS) leaders, industry vendors, and guest speakers for an event focused on best practices, innovation, and the future of EVS. The trade show was planned and led by the…
At the end of the day, when patients and doctors are unable to effectively engage in health care conversations, the quality of care and patient health suffer, resulting in rising U.S. healthcare costs, lower quality of care, and unhealthy patients. The post Rekindling the Doctor, Patient Relationship appeared first on MedCity News.